Holistic | New Studies | Prognosis | Research
Risk for Malnutrition Among Older Mesothelioma Patients
A new study out of Brazil suggests that many older mesothelioma patients may be at risk for malnutrition and the…
-
-
First-Line Keytruda Treatment May Support Longer Mesothelioma Survival
New data suggests first-line Keytruda treatment helps lung cancer patients more than chemotherapy – even if chemotherapy patients add Keytruda… -
Biomarkers | Diagnosis | Europe | International | New Studies | Research
Lung Cancer Blood Test: Can it Find Early Mesothelioma?
Mesothelioma patients and their doctors may have reason to be optimistic about a new lung cancer blood test. A random… -
New Hope for Relapsed Pleural Mesothelioma?
There is new evidence that adding a drug called vorinostat to immunotherapy might help relapsed pleural mesothelioma patients. The new… -
Effect of Chemotherapy on Immunotherapy for Mesothelioma
Belgian scientists say they are still not sure about the effect of chemotherapy on immunotherapy for mesothelioma. They reached that… -
Pleural Mesothelioma Rates Remain Stagnant As Survival Improves
A new report shows pleural mesothelioma rates in the US have failed to decline as they were predicted to do,… -
Alternatives | Europe | Holistic | International | New Studies | Research
Curcumin Supplement Delays Mesothelioma Tumor Growth in Mice
Italian researchers say a curcumin supplement containing a compound found in black pepper slowed the growth of mesothelioma tumors in… -
Chemotherapy | Europe | International | New Studies | Research | Treatments
Isolated Thoracic Perfusion for Mesothelioma Symptom Relief
A new study suggests that a treatment called isolated thoracic perfusion could help alleviate some of the worst symptoms of… -
Keto Diet for Mesothelioma Not Advised Despite New Research
New research suggests a diet low in carbs and sugar may slow the growth of certain kinds of cancer cells.… -
New Mesothelioma Immunotherapy Trial Now Underway at Baylor
Cancer researchers at Baylor College of Medicine have launched a new mesothelioma immunotherapy trial. The trial combines the cancer drug…
